Aleph Farms, a cellular agriculture company developing a scalable biomanufacturing platform for the food and broader bio-based industries, announced the successful completion of the first phase of a collaboration with UK-based biotechnology company Roslin Technologies, a leading developer of advanced animal cell lines for cellular agriculture applications. “This milestone demonstrates, for the first time, that cells developed by an external organization can grow successfully using Aleph Farms’ proprietary growth medium, confirming that the company’s core technology can support cell cultivation for multiple partners and applications,” the company states.
During the evaluation phase, Roslin Technologies’ bovine cell line was cultivated using Aleph Farms’ growth media, reportedly confirming robust performance across independently developed cell lines. The results are said to highlight the flexibility of the enabling technology and its potential for cost-efficient, animal-component-free production across multiple sectors, while further reinforcing the commercial relevance of Roslin Technologies’ cell lines for integration into diverse production environments.
This milestone forms part of Aleph Farms’ broader strategy to build a global partner network around its biomanufacturing platform. Together with collaborations across Europe and Asia involving manufacturing, technology, and research partners, the Roslin Technologies collaboration demonstrates a distributed, partner-enabled approach to scalable cell-based production. Aleph Farms continues to explore additional partnerships to apply its platform across new cell types, applications, and industrial sectors.
“This collaboration marks an important step in demonstrating that our core technology platform can support cell cultivation beyond our own internal programs,” said Neta Lavon, Co-Founder and Chief Technology Officer of Aleph Farms. “As industrial biomanufacturing expands across food and other bio-based industries, enabling platforms that can support multiple partners, cell types, and production systems will be essential to unlocking scalable global deployment.”
“We are pleased to collaborate with Aleph Farms and evaluate the performance of our bovine cell lines using their growth media technology,” said Deepika Rajesh, Chief Scientific Officer at Roslin Technologies. “Demonstrating cross-platform compatibility is a key step in validating our cell lines for broad B2B deployment, and collaborations like this help advance robust, scalable cultivation systems that can benefit the whole next-generation biomanufacturing industry.”
The partners state that following the successful completion of the initial phase, the companies are advancing into a second phase of collaboration that will evaluate additional species and cell types, further expanding the scope of the platform. This work also supports Aleph Farms’ broader cost-reduction roadmap, as outlined in the company’s recently completed techno-economic analysis demonstrating a pathway toward scalable, commercially viable production.
